Dovato 50-300 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FP6A6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,414
Award facts
- Contract value 100% obligated
- $44,413.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $44,413.60 to AmerisourceBergen Drug Corp for DOVATO 50-300 mg tablets (30-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999.99 million and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages this prime IDC to supply a broad spectrum of pharmaceutical products and medical supplies to support federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. DOVATO is an antiretroviral medication used in HIV treatment, and this particular delivery order reflects the company's established capability to fulfill specialized pharmaceutical requirements through the DLA's Medical Supply Chain. The contract award demonstrates AmerisourceBergen's competitive standing within the federal pharmaceutical procurement landscape, as the company anticipates potential involvement in DLA Troop Support's forthcoming Pharmaceutical Prime Vendor Global Program Generation V initiative, which will involve multiple regional awards.
Quick answers
Who was awarded contract SPE2DB25FP6A6?
SPE2DB25FP6A6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FP6A6 worth?
The government has obligated $44,414 on SPE2DB25FP6A6.
Is contract SPE2DB25FP6A6 an order under another contract?
Yes. SPE2DB25FP6A6 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FP6A6 competed?
The extent of competition for SPE2DB25FP6A6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award